88IV - PR Newswire Asia's news - Infectious Disease Control

< Previous page

| Title only | Print

Next page >

HSA approves GSK's Arexvy, the world's first respiratory syncytial virus (RSV) vaccine for older adults [1] Arexvy has been approved by the Health Sciences Authority (HSA) of Singapore for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus ... 2024-05-16T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Animal Quarantine Service Uncovers Foreign National Attempting to Bring Livestock Products into Japan Illegally TOKYO , May 15, 2024 /PRNewswire/ -- Last year, the Animal Quarantine Service (AQS) uncovered a foreign national who illegally brought meat such as sausages containing pork, which are prohibited from ... 2024-05-15T Food/Beverages Health Care/Hospital Infectious Disease Control
Everest Medicines Announces Commercial Launch and First Prescription for NEFECON® in Mainland China SHANGHAI , May 14, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, ... 2024-05-14T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Pfizer Receives Authorization from Health Authority for the First Dual Indication Vaccine Approved in Hong Kong A Vaccine to Fight Against Respiratory Syncytial Virus (RSV) in Older Adults Aged 60 and Above and Infants (Through Maternal Immunization) ... 2024-05-08T Infectious Disease Control
INTREPID Alliance Landscape of Promising Antivirals in Clinical Development Reveals Gaps in Global Defense Against Potential Future Pandemics Detailed scientific analysis of antiviral pipeline identifies most promising clinical compounds aligned with 100 Days Mission global preparedness recommendations ... 2024-04-29T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Fosun Pharma's Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa SHANGHAI , April 26, 2024 /PRNewswire/ -- World Malaria Day is marked each year on April 25 . World Health Organization (WHO) gave as the theme for World Malaria Day 2024 Accelerating the fight ... 2024-04-26T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil "Aiming to offer a Dengue antiviral treatment course in $100 price range" Hyundai Bioscience decides to conduct dengue clinical trials in Brazil , which has the largest number of Dengue ... 2024-04-25T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Landmark New Publication: the Forgotten Biochemistry 101 of COVID-19 Legacy coronavirus biochemistry was overlooked that governs spike protein toxicity, key morbidities, risk factors and therapeutic responses ... 2024-04-22T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization SEOUL, South Korea , April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com ) announced on April 15 that it would carry ... 2024-04-19T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Global clinical development on Dengue antiviral candidate will start, Hyundai Bioscience strives to win emergency use authorization SEOUL, South Korea , April 19, 2024 /PRNewswire/ -- South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com ) announced on April 15 that it would carry ... 2024-04-19T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2024

Suntek Computer Systems Limited.

All rights reserved